Matrix metalloproteinases and TIMPs: properties and implications for the rheumatic diseases
- 1 March 1998
- journal article
- review article
- Published by Elsevier in Molecular Medicine Today
- Vol. 4 (3), 130-137
- https://doi.org/10.1016/s1357-4310(97)01192-1
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- OsteoarthritisThe Lancet, 1997
- Relating matrix metalloproteinase structure to function: Why the “hemopexin” domain?Matrix Biology, 1997
- PATHOGENESIS OF RHEUMATOID ARTHRITISMedical Clinics of North America, 1997
- Collagenase: a key enzyme in collagen turnoverBiochemistry and Cell Biology, 1996
- Metalloproteinase inhibitors and the prevention of connective tissue breakdownPharmacology & Therapeutics, 1996
- COLLAGENS: Molecular Biology, Diseases, and Potentials for TherapyAnnual Review of Biochemistry, 1995
- Using inhibitors of metalloproteinases to treat arthritis. Easier said than done?Arthritis & Rheumatism, 1994
- [1] Classification of peptidasesMethods in Enzymology, 1994
- The measurement of collagenase, tissue inhibitor of metalloproteinases (timp), and collagenase—timp complex in synovial fluids from patients with osteoarthritis and rheumatoid arthritisArthritis & Rheumatism, 1993
- Matrix Metalloproteinases: A ReviewCritical Reviews in Oral Biology & Medicine, 1993